tm
Seeing Is Believing
tm
Seeing Is Believing
ADMA is currently covered by 4 analysts with an average potential upside of $4.17 (122.01%) backed by displayed 10 price targets and 36 ratings.
Analysts average stock forecasts to be materialized ratio is 26.9% with an average time for these price targets to be met of 253.86 days.
Highest price target for ADMA is 4, Lowest price target is 1, average price target is 2.5.
Most recent stock forecast was given by ELLIOT WILBUR from RAYMOND JAMES on 10-Aug-2023. First documented stock forecast 02-Dec-2013.
Currently, out of the existing stock ratings of ADMA - 18 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
6
$2.45 (69.01%)
5
1 months 11 days ago
0/8 (0%)
$3.74 (199.68%)
Buy
5
$1.45 (40.85%)
4.5
1 months 11 days ago
4/5 (80%)
$1 (33.84%)
211
Buy
6
$2.45 (69.01%)
4.5
1 months 11 days ago
1/2 (50%)
$2.4 (130.32%)
642
Buy
5
$1.45 (40.85%)
10
11 months 8 days ago
0/4 (0%)
$4.37 (146.09%)
Buy
4
$0.45 (12.68%)
14
2 years 10 months 15 days ago
1/3 (33.33%)
$6.93 (191.15%)
917
What is ADMA (ADMA Biologics) average time for price targets to be met?
Which analyst has the current highest performing score on ADMA (ADMA Biologics) with a proven track record?
Which analyst has the current lower performing score on ADMA (ADMA Biologics) with a proven track record?
Which analyst has the most public recommendations on ADMA (ADMA Biologics)?
Which analyst is the currently most bullish on ADMA (ADMA Biologics)?
Which analyst is the currently most reserved on ADMA (ADMA Biologics)?
